Related Experiment Video

Updated: Aug 24, 2026

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy
10:55

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy

Published on: October 31, 2025

Paediatric idiopathic inflammatory muscle disease

Lucy R Wedderburn1, Charles K C Li

  • 1Rheumatology Unit, Institute of Child Health, University College London, 30 Guilford Street, London WC1N 1EH, UK. l.wedderburn@ich.ucl.ac.uk

Best Practice & Research. Clinical Rheumatology
|May 26, 2004
PubMed

Insights

Paediatric idiopathic inflammatory myopathies (IIMs), particularly juvenile dermatomyositis (JDM), are rare childhood autoimmune diseases. Recent advancements focus on improved diagnostics, disease assessment, and novel JDM treatments.

Area of Science:

  • Pediatric Rheumatology
  • Autoimmune Diseases
  • Systemic Inflammatory Conditions

Background:

  • Paediatric idiopathic inflammatory myopathies (IIMs) are rare, serious systemic autoimmune conditions affecting children.
  • Juvenile dermatomyositis (JDM) is the most common IIM in children, distinct from adult dermatomyositis.
  • Juvenile myositis can co-occur with other autoimmune diseases like scleroderma and lupus erythematosus.

Purpose of the Study:

  • To review recent developments in the diagnosis, clinical presentation, and disease course of paediatric IIMs.
  • To discuss advancements in disease assessment tools and therapeutic strategies for JDM.
  • To explore emerging research on the pathogenesis of paediatric IIMs.

Main Methods:

  • Literature review of recent studies on paediatric IIMs.
  • Analysis of diagnostic criteria evolution for JDM.
  • Synthesis of data on disease activity measurement and treatment outcomes.

Main Results:

  • Significant progress has been made in developing and validating tools for measuring disease activity and damage in paediatric IIMs.
  • New therapeutic approaches are increasingly utilized for treating JDM.
  • Understanding of JDM's distinct clinical spectrum compared to adult dermatomyositis has improved.

Conclusions:

  • The review highlights key advancements in understanding and managing paediatric IIMs, especially JDM.
  • Improved diagnostic and assessment tools are enhancing patient care.
  • Ongoing research into pathogenesis promises further therapeutic innovations for these rare childhood conditions.

Related Concept Videos

Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...